To determine the impact of NRF2 inhibition on the redox microenvironment in FLT3 mutant AML cells, we treated MOLM13 and MOLM13-TKIR cells with brusatol and then measured intracellular peroxide levels using DCF-DA staining (Figure 4A). This evidence concerns the gene FLT3 and acute myeloid leukemia.